NeuroMetrix, Inc. (NURO) Stock Analysis
DELISTED 2025
What happened to NeuroMetrix, Inc. (NURO) stock?
NeuroMetrix, Inc. (NURO) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- May 2025
- Last recorded price (historical):
- $4.58 (last quote on record before the May 2025 delisting; historical, not a current quote)
Market cap $9.43M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
NeuroMetrix, Inc. (NURO). NeuroMetrix, Inc. develops, manufactures, and distributes specialized medical devices for nerve function evaluation and stimulation, serving both diagnostic and therapeutic needs globally.
Last analyzed: Jun 14, 2026NeuroMetrix, Inc. (NURO) Healthcare & Pipeline Overview
More about this archive record
Can I still buy NURO shares?
No. NURO stopped trading on public markets in May 2025, so the shares are not available through a broker. Anything you see quoted for NURO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before NURO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to NeuroMetrix, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.